Investor presentation on the unaudited financial results for the quarter ended June 30, 2026.

FY26 results: Standalone: Revenue 50.5bn +116% y-y (23.4bn) EBITDA 17.3bn +140% y-y (7.2bn) EBITDA margin 34.3% (31.0%) +330 bps y-y PAT 10.8bn +193% y-y (3.7bn) Consolidated: Revenue 50.5bn +116% y-y (23.4bn) EBITDA 17.3bn +140% y-y (7.2bn) EBITDA margin 34.3% (31.0%) +330 bps y-y PAT 10.8bn +193% y-y (3.7bn) Q1FY27 results (unaudited): Standalone: Revenue 15.6bn +51% y-y (10.3bn) EBITDA 5.5bn +56% y-y (3.5bn) EBITDA margin 35.2% (34.1%) +110 bps y-y PAT 3.8bn +103% y-y (1.9bn) Consolidated: Revenue 15.6bn +51% y-y (10.3bn) EBITDA 5.5bn +56% y-y (3.5bn) EBITDA margin 35.2% (34.1%) +110 bps y-y PAT 3.8bn +103% y-y (1.9bn) Dividend: Not stated Commentary: Record quarterly performance with strong operational momentum and margin expansion driven by operating leverage and increased internal cell consumption.